https://research.ouhsc.edu/news Parent Page: News id: 26727 Active Page: detailsid:26917

News

OUHSC Research News – Monday, August 15, 2022


Published: Friday, August 12, 2022

OUHSC Research News – Monday, August 15, 2022

Notices and Reminders

SoonerTrack II Announcement

The Office of Research Administration (ORA) is pleased to announce that the SoonerTrack II system is now fully operational! All proposals must be routed through the new system for review, institutional approval, and submission to the sponsor.  The launch webpage for the system is https://fs.ou.edu. User guides and training materials are available at https://research.ouhsc.edu/research-administration/soonertrack-ii-support.  If you have any questions, please contact soonertrackhelpdesk@ouhsc.edu.

 

Important SoonerTrack Updates

Please note that to be added to routing forms as Principal Investigator (PI) or personnel, you must log into https://fs.ou.edu as soon as possible. Other than logging in and out, you do not need to do anything else at this time. However, if you do not perform this initial login step, your department support will not be able to route forms for you nor will other researchers be able to add you to their projects in SoonerTrack.

If you are routing a proposal/agreement in SoonerTrack II and can’t find your department, please contact your business administrator. If you have any questions, please contact us at soonertrackhelpdesk@ouhsc.edu.

 

SoonerTrack II Live Q&A sessions

Have a question about the new SoonerTrack system? The Office of Research Administration (ORA) invites you to attend one of the SoonerTrack II Q&A sessions listed below, where you will have the opportunity to ask questions and receive answers from the subject matter experts. Registration is required. All sessions will be hosted virtually via Zoom. Questions may also be submitted ahead of time to soonertrackhelpdesk@ouhsc.edu.     

SoonerTrack II Live Q&A Sessions

  1. August 17, 2022 10:30 AM – 11:30 AM      Register here
  2. August 24, 2022 10:30 AM – 11:30 AM      Register here
  3. August 31, 2022 10:30 AM – 11:30 AM      Register here

 

Office of the Vice President for Research announces new Leadership for the Institutional Research Core Facility

James F. Papin, Ph.D. has been named as Director of the Institutional Research Core Facility, commonly referred to as the Laboratory for Molecular Biology and Cytometry Research (LMBCR).  Dr. Papin started in this new role as of July 25th and is contingent on final Board of Regents approval at their next meeting. Dr. Papin graduated from Oklahoma City University where he received a Bachelor of Science with honors in Biology before coming to the University of Oklahoma Health Sciences Center (OUHSC) where he earned his Ph.D. in the Department of Microbiology and Immunology. Following his doctoral studies on herpesviruses, Dr. Papin was a postdoctoral fellow at the University of California, Davis and at Boston University where he continued his research in the fields of virology and vaccine development.

In 2010, Dr. Papin returned to the OUHSC as a faculty member in the Department of Pathology. During his time at OUHSC, Dr. Papin has been promoted to Associate Professor and he has served the campus in several leadership roles, including as the Director of the High Containment Biosafety Level 3 Laboratory and as the Institutional Biosafety Officer. He also has served on several important institution-wide oversight committees, including the Institutional Biosafety Committee and the Institutional Animal Care and Use Committee.

Along with his new duties as Director of the Institutional Research Core Facility, Dr. Papin will oversee the Technical Service Unit in the Division of Comparative Medicine as Associate Director.  He also continues to pursue his highly productive independent research program focused on virology and vaccine development.

Some of his initial goals as Director of the Institutional Research Core Facility will be to enhance customer service and oversight of all research units within the Core Facility.  He will also work closely with faculty utilizing Core services and ensure the Core capabilities and equipment resources can be easily accessed by all faculty and trainees and that these resources are widely communicated throughout the research community. 

We look forward to his leadership in this position where he will support the advancement of outstanding research at OUHSC and help our faculty achieve nationally recognized research outcomes using cutting edge research technology.

 

The Office of Vice President for Research (OVPR) and the Office of Research Administration (ORA) at the OU Health Sciences Center Announcing the Launch of the Newly Redesigned Website

We are excited to announce the launch of our newly redesigned website. The new design allows for streamlined menus and clear navigation, and offers quick and easy access to essential information for our faculty and staff. Explore the website at https://research.ouhsc.edu. We welcome your feedback. Please send any questions or comments to oradmin@ouhsc.edu.

 

Workshops and Seminars

Webinar II: Diving Deeper into the New NIH Data Management and Sharing Policy 

Date: Thursday, September 22, 2022 / 12:30 - 2:30 PM (Central)

Description: The NIH Office of Science Policy (OSP) and the Office of Extramural Research (OER) invite you to join them for an engaging and interactive webinar focused on the new DMS policy which goes into effect on January 25, 2023. In this second webinar of the series, we will expand upon the information presented in the first webinar and dive deeper into topics including privacy protections for data from human participants and justifiable limitations on sharing data. Don't miss this valuable opportunity to hear policy experts provide the latest information and to get your questions answered.

Registration: https://vfairs.zoom.us/webinar/register/WN_3y9GFMc2SsWpv2GhIzOGsg

 

SAVE THE DATE! 2022 END2CANCER
OU Health Stephenson Cancer Center is proud to host the 2022 END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer conference from December 1-2, 2022 in Oklahoma City, Oklahoma, USA. The END2CANCER conference will start the morning of December 1, 2022 and conclude in the afternoon of December 2, 2022. The conference will bridge laboratory research conducted in the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging and treatment of cancer. The conference will host keynote, plenary and invited lectures by eminent scientists who will discuss new and emerging concepts, technologies and challenges in translating nanomedicine from bench-to-bedside.
Topics to be discussed in the planned thematic sessions include Gene and Drug Delivery, Immuno-Oncology, Drug Discovery and New Drugs on the Horizon for Clinical Translation, Extracellular Vesicles, Combinatorial Therapeutics, and more to come. 
The multi-disciplinary two-day conference will bring together physicians, basic scientists, engineers, physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates, business professionals, educators and technology transfer specialists. Students and fellows will have an opportunity to present their work and compete for cash awards. We will again be hosting a special session titled "Art of Science in Light of Nanomedicine" will allow participants to display their best research as a photo with a caption and compete for a cash prize.

 

OUHSC Funding Opportunities

Investigator Initiated Trials Funding Committee (IITFC), Clinical Trials Office-Protocol Support Unit

Description: Grant proposals are being accepted for the Fall cycle from Stephenson Cancer Center Providers for their investigator-initiated clinical trials (IITs) or translational work for the amount of up to $125,000 for clinical trials, and up to $25,000 for translation research. All applications should be submitted to the Protocol Support Unit at SCC-IIT-Office@ouhsc.edu and should adhere to the Submission Checklist provided with this notice.

Deadline: October 3, 2022 at 5 pm CST

Link to the full announcement or a flyer: Please refer to the attached flyer.

 

Trainee Research Conference and Workshop Award
Description: The Stephenson Cancer Center (SCC) is pleased to offer Research Conference and Workshop awards for participation in professional meetings and workshops. These awards are available to graduate students, professional students, and postdoctoral fellows at the University of Oklahoma Health Sciences Center (OUHSC) and University of Oklahoma (OU) main campus. This includes medical students, residents and fellows, as well as fulltime faculty who are currently enrolled in a graduate or professional degree program. The SCC intends to give up to 8 of these awards to cover meetings and conferences held between November 1, 2022 and April 30, 2023. See below for more information.
Financial Support: Up to $1000 will be awarded per applicant to support the registration fees, airfare, hotel and other related expenses. The above and other qualifying expenses will be reimbursed per the University of Oklahoma’s Travel Reimbursement policy.

How to Apply: Interested applicants should complete the Online Application Form and include all required application materials. Complete applications must be submitted on or before the following application deadlines:

  • September 18, 11:59 PM CST, for Winter/Spring Meetings or Workshops being held between November 1 and April 30.

We understand that trainees may not be aware of abstract acceptance and other details at by the above deadline. Please still apply. If awarded, trainee should update the Program Manager as details are known.

More information: Please contact the Program Manager. Please refer the attached flyer.

 

Office of Technology Commercialization presents the following opportunities for researchers to engage with industry (click here for more information, or email otc@ou.edu or gina-mcmillen@ouhsc.edu).  

  • ELI Lilly is seeking druggable targets for weight loss, in particular approaches focused on appetite modulation, energy expenditure and mechanisms synergistic with GLP-1.  All mechanisms and modalities are of interest as is drug repurposing.  Out of scope includes plant/food based approaches and probiotics/microbiome targeting (unless weight loss is robust). Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 08/25).
  • A multinational restorative dentistry company is looking for novel 3D scanning technologies that can be applied to the oral environment, for use to improve methods for structured light scanning (i.e. improved speed, reduced costs, improved accuracy, and ease of use).  Technology should be able to achieve resolution in the 25-50 micron range and acquire color imaging.  Submission entails a 1-pg non-confidential summary of technology with optional supplemental information.  (deadline 09/02).

 

 NIH Notices 

NOTE: When only one application is allowed per Institution according to the sponsor instructions, a one-page letter of intent summarizing the proposed project should be submitted to the Vice President for Research at least two months prior to the application deadline (unless otherwise noted).  The letters of intent will be reviewed and a single application will be chosen for submission from the University.

 

NIH Funding Opportunities

 

Other Funding Opportunities

AACR Clinical Oncology Research (Core) Training Fellowships

Description: This fellowship is designed for early-career clinical scientists who hold a medical degree (MD, DO, or MD/PhD) and are interested in acquiring the knowledge and skills related to drug development from the perspective of the pharmaceutical industry. The fellow will gain real-world experience in drug development, including clinical research, clinical trial design, and data analysis.

Application Deadline: August 31, 2022

Link to Full Announcement: https://www.aacr.org/grants/aacr-clinical-oncology-research-core-training-fellowships/

 

The International Center for Responsible Gaming - ICRG Center of Excellence for Gambling Research

Description: The purpose of this funding opportunity is to advance development, implementation and validation of interventions to minimize gambling-related harm through responsible gambling programs. The ICRG is especially interested in understanding and addressing the low usage of responsible gambling tools. Applicants may request up to $402,500 for a three-year grant.

Application Deadline: October 1, 2022

Link to Full Announcement: https://www.icrg.org/research-center/apply-icrg-funding

 

The International Center for Responsible Gaming - Large Grant on Gambling among Emerging Adults

Description: The International Center for Responsible Gaming (ICRG) invites investigators to apply for research grants to study gambling and gambling problems among emerging adults in the US. Applicants may request up to $172,500 for a two-year grant.

Application Deadline: October 1, 2022

Link to Full Announcement: https://www.icrg.org/research-center/apply-icrg-funding

 

The Melanoma Research Alliance (MRA) - Patient-Centric Clinical Trial Team Science Awards

Description: The Melanoma Research Alliance (MRA) is pleased to announce a Special Opportunity RFP for Team Science Awards focused on patient-centric clinical trials, jointly funded by The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and MRA. MRA and RTFCCR will jointly support two team awards (each up to $1.5 million) for clinical trials with the potential to provide significant impact to melanoma patients. These awards seek to support novel, interventional clinical trials with the goal of making a significant difference to melanoma patients in the short term. Patient engagement must be actively demonstrated throughout the full life cycle of the clinical trial, including planning and dissemination.

Letters of Intent Due: October 5, 2022

Invited Full Proposals Due: January 18, 2023

Link to Full Announcement: CureMelanoma.org/RFP

 

Oklahoma Center for Adult Stem Cell Research (OCASCR)

Description: The overall goal of OCASCR is to help adult stem cell and regenerative medicine research thrive in Oklahoma and to serve as a trusted resource for public information on these topics. Grants are accepted for research, equipment, and travel/education, and other areas.

Application Deadline: September 20, 2022

Link to Full Announcement: http://www.ocascr.org/grants/

 

The International Center for Responsible Gaming - Small Grants for Research on Lottery Gambling

Description: The International Center for Responsible Gaming and the Hoosier Lottery are collaborating on a special initiative to encourage research on responsible gambling as it relates to lottery gambling. Research projects may include but are not limited to: 

  • Stand-alone research projects or a pilot project; 
  • Preliminary research in preparation for a large research project, such as a comprehensive literature review, or instrument development and testing; and 
  • Research tasks subsequent to a full research project, such as follow-up testing. 

Applicants may request up to $25,000 in direct costs and $5,000 in Facilities and Administration costs

Application Deadline: September 1, 2022

Link to Full Announcement: https://www.icrg.org/research-center/apply-icrg-funding

 

DoD FY22 Peer Reviewed Cancer Research Program (PRCRP)

  • Behavioral Health Science Award (BHSA)

Pre-Application (Letter of Intent): September 28, 2022

Application: October 20, 2022

  • Career Development Award (CDA) – Scholar Option

Pre-Application (Letter of Intent): September 28, 2022

Application: October 20, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/prcrp

 

DoD FY22 Breast Cancer Research Program (BCRP)

  • Breakthrough Award Levels 1 and 2 II (BTA12-2)
  • Era of Hope Scholar Award II (EOHS-2)

Pre-Application (Letter of Intent): September 22, 2022
Application: October 6, 2022 

  • Breakthrough Award Level 3 II (BTA3-2)
  • Breakthrough Award Level 4 II (BTA4-2)
  • Innovator Award II (INNOV-2)

Link to Full Announcement: https://cdmrp.army.mil/funding/bcrp

 

DoD FY22 Melanoma Research Program (MRP)

  • Melanoma Academy Scholar Award (MASA)
  • Mid-Career Accelerator Award (MCAA)
  • Team Science Award (TSA)
  • Focused Program Award – Rare Melanomas (FPA)

Pre-Application (Letter of Intent): September 14, 2022
Application: October 5, 2022

Link to Full Announcement: https://cdmrp.army.mil/funding/mrp

 

HRSA Geriatrics Academic Career Award (GACA) Program

Description: The purpose of the GACA program is to support the career development of junior faculty as academic geriatricians or academic geriatrics specialists.

The goals of the program are for the GACA candidate to: a) develop the necessary knowledge and skills to lead health care transformation in a variety of settings, including rural and/or medically underserved settings, b) be age-friendly, and c) provide training in clinical geriatrics, including the training of interprofessional teams of healthcare professionals to provide healthcare for older adults.

Application Deadline: 8/5/2022 to 11/4/2022

Link to Full Announcement: https://www.hrsa.gov/grants/find-funding/HRSA-23-007

Documents to download